Holen Sie sich die Stockscreener-App
81.66
4.01%
3.15
Handel nachbörslich:
80.10
-1.56
-1.91%
Schlusskurs vom Vortag:
$78.51
Offen:
$77.99
24-Stunden-Volumen:
480.98K
Relative Volume:
1.69
Marktkapitalisierung:
$1.18B
Einnahmen:
$1.80M
Nettoeinkommen (Verlust:
$1.76B
KGV:
0.6881
EPS:
118.674
Netto-Cashflow:
$-149.23M
1W Leistung:
+42.54%
1M Leistung:
+142.46%
6M Leistung:
+562.29%
1J Leistung:
+409.42%
1-Tages-Spanne:
$75.13
$83.95
1-Wochen-Bereich:
$53.39
$83.95
52-Wochen-Spanne:
$10.80
$83.95
Inhibrx Biosciences Inc Stock (INBX) Company Profile
Firmenname
Inhibrx Biosciences Inc
Sektor
Branche
Telefon
(858) 795-4220
Adresse
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
Vergleichen Sie INBX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
81.66 | 1.14B | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-23 | Eingeleitet | JMP Securities | Mkt Perform |
| 2024-01-23 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-09-21 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-09-14 | Eingeleitet | Credit Suisse | Outperform |
| 2020-09-14 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Inhibrx Biosciences Inc Aktie (INBX) Neueste Nachrichten
Is Inhibrx Biosciences Inc. stock resilient to inflationEntry Point & Stepwise Trade Signal Implementation - newser.com
Tick level data insight on Inhibrx Biosciences Inc. volatilityFed Meeting & Safe Capital Allocation Plans - newser.com
Inhibrx Biosciences Inc. stock daily chart insightsJobs Report & Free AI Powered Buy and Sell Recommendations - newser.com
Why Inhibrx Biosciences Inc. stock appeals to analysts2025 Sector Review & Consistent Profit Trading Strategies - newser.com
Will Inhibrx Biosciences Inc. stock benefit from sector rotation2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - newser.com
Ethic Inc. Purchases New Shares in Inhibrx Biosciences, Inc. $INBX - MarketBeat
Inhibrx Biosciences stock hits all-time high of 83.93 USD By Investing.com - Investing.com Australia
Inhibrx Biosciences stock hits all-time high of 83.93 USD - Investing.com
What does recent volatility data suggest for Inhibrx Biosciences Inc.Quarterly Risk Review & AI Optimized Trading Strategy Guides - newser.com
Biotech Stocks Hit 52-Week Highs: MTSR, INSM, ABVX, MAZE Lead October 30 Surge - RTTNews
What Wall Street predicts for Inhibrx Biosciences Inc. stock priceJuly 2025 Breakouts & Free Community Consensus Stock Picks - newser.com
How to recover losses in Inhibrx Biosciences Inc. stock2025 Short Interest & Community Verified Trade Signals - newser.com
Inhibrx Biosciences (NASDAQ:INBX) Trading Up 7.8%What's Next? - MarketBeat
Published on: 2025-10-30 05:00:27 - newser.com
Published on: 2025-10-30 02:27:04 - newser.com
Inhibrx Biosciences (NASDAQ:INBX) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Regression analysis insights on Inhibrx Biosciences Inc. performanceTrade Exit Report & Community Consensus Picks - newser.com
Inhibrx Biosciences (NASDAQ:INBX) Hits New 12-Month HighHere's What Happened - MarketBeat
How hedge fund analytics apply to Inhibrx Biosciences Inc. stockTrade Volume Summary & Low Drawdown Momentum Ideas - newser.com
Published on: 2025-10-28 03:10:26 - newser.com
Published on: 2025-10-28 00:45:26 - newser.com
How Inhibrx Biosciences Inc. stock valuations compare to rivalsMarket Movement Recap & Daily Entry Point Trade Alerts - Fundação Cultural do Pará
Is Inhibrx Biosciences Inc. stock supported by innovation pipelineJuly 2025 Selloffs & Entry Point Confirmation Signals - fcp.pa.gov.br
Is Inhibrx Biosciences Inc. stock recession proof2025 Trade Ideas & Free Community Consensus Stock Picks - Fundação Cultural do Pará
Inhibrx Biosciences: Cruising Toward FDA Approval, But Getting Ahead Of Itself - Seeking Alpha
Multi factor analysis applied to Inhibrx Biosciences Inc.Price Action & Real-Time Volume Trigger Notifications - newser.com
What high frequency data says about Inhibrx Biosciences Inc.Earnings Overview Summary & Low Volatility Stock Suggestions - newser.com
US Stocks Jump To Records Amid Weak Inflation: Investor Fear Eases, Greed Index Remains In 'Fear' Zone - NewsBreak: Local News & Alerts
Inhibrx Preps US Filing For Ozekibart In Rare Bone Cancer After Phase II Win - Citeline News & Insights
Finanzdaten der Inhibrx Biosciences Inc-Aktie (INBX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):